Low‑molecular weight fucoidan inhibits the differentiation of osteoclasts and reduces osteoporosis in ovariectomized rats

Jin,Xin; Zhu,Liguo; Li,Xiulan; Jia,Jian; Zhang,Yang; Sun,Xiaolei; Ma,Jianxiong; Liu,Zhaojie; Ma,Xinlong

doi:10.3892/mmr.2016.6062

Low‑molecular weight fucoidan inhibits the differentiation of osteoclasts and reduces osteoporosis in ovariectomized rats

Authors:
- Xin Jin
- Liguo Zhu
- Xiulan Li
- Jian Jia
- Yang Zhang
- Xiaolei Sun
- Jianxiong Ma
- Zhaojie Liu
- Xinlong Ma
View Affiliations

Affiliations: Orthopedics Department, Tianjin Hospital, Tianjin 300050, P.R. China, Orthopedics Department, China Academy of Traditional Chinese Medicine, Beijing 100102, P.R. China
Published online on: December 20, 2016 https://doi.org/10.3892/mmr.2016.6062
Pages: 890-898

Metrics: Total Views: 0 (Spandidos Publications: | PMC Statistics: )

Metrics: Total PDF Downloads: 0 (Spandidos Publications: | PMC Statistics: )

Cited By (CrossRef): 0 citations Loading Articles...

Abstract

Fucoidan is a type of sulfated polysaccharide isolated from seaweed. The present study used ovariectomized Sprague‑Dawley rats, which were treated with fucoidan. The effects of fucoidan on bone metabolism, density and microarchitecture were assessed using micro‑computed tomography (CT), histomorphometric analysis, biochemical markers of bone metabolism (Serum procollagen type I N propeptide and C‑terminal telopeptide‑1) and tests of mechanical competence of the femur. In addition, the effects of low‑molecular weight fucoidan (LMWF) on in vitro cultured osteoclasts were examined, in order to determine the mechanisms underlying LMWF‑induced osteoclastic inhibition. In ovariectomized rats, LMWF increased femoral bone density. Micro‑CT scan also revealed that LMWF prevented microarchitectural deterioration and histomorphometric analysis determined that LMWF increased trabecular bone number and reduced the surface of bone resorption. In addition, LMWF reduced the high bone turnover rate, and improved the mechanical properties of the femur in ovariectomized rats. In vitro experiments revealed that LMWF inhibited the receptor activator of nuclear factor κB ligand (RANKL) and macrophage colony‑stimulating factor‑induced differentiation of RAW264.7 cells into tartrate‑resistant acid phosphatase (TRAP)‑positive osteoclasts, and reduced the bone resorption surface of the osteoclasts. Reverse transcription‑quantitative polymerase chain reaction demonstrated that LMWF inhibited mRNA expression of TRAP, matrix metallopeptidase‑9, nuclear activator of activated T‑cells 1, and osteoclast‑associated immunoglobulin‑like receptor, which are components of the signaling pathway for osteoclast differentiation. LMWF had no effect on RANK mRNA expression. In conclusion, the present study confirmed that LMWF inhibited osteoclast differentiation and bone resorption, and may be a potential treatment for osteoporosis in ovariectomized rats.

View Figures

View References

1	Melton LJ III, Chrischilles EA, Cooper C, Lane AW and Riggs BL: How many women have osteoporosis? JBMR Anniversary Classic. JBMR. 7(9)1992.J Bone Miner Res. 20. 886–892. 2005.
2	Sowers MR, Zheng H, Jannausch ML, McConnell D, Nan B, Harlow S and Randolph JF Jr: Amount of bone loss in relation to time around the final menstrual period and follicle-stimulating hormone staging of the transmenopause. J Clin Endocrinol Metab. 95:2155–2162. 2010. View Article : Google Scholar : PubMed/NCBI
3	Ritchie RO, Buehler MJ and Hansma P: Plasticity and toughness in bone. Phys Today. 62:41–47. 2009. View Article : Google Scholar
4	Zimmermann EA, Schaible E, Bale H, Barth HD, Tang SY, Reichert P, Busse B, Alliston T, Ager JW III and Ritchie RO: Age-related changes in the plasticity and toughness of human cortical bone at multiple length scales. Proc Natl Acad Sci USA. 108:14416–14421. 2011. View Article : Google Scholar : PubMed/NCBI
5	Fitzpatrick P, Kirke PN, Daly L, Van Rooij I, Dinn E, Burke H, Heneghan J, Bourke G and Masterson J: Predictors of first hip fracture and mortality post fracture in older women. Ir J Med Sci. 170:49–53. 2001. View Article : Google Scholar : PubMed/NCBI
6	Matsuo K: Cross-talk among bone cells. Curr Opin Nephrol Hypertens. 18:292–297. 2009. View Article : Google Scholar : PubMed/NCBI
7	Teitelbaum SL: Bone resorption by osteoclasts. Science. 289:1504–1508. 2000. View Article : Google Scholar : PubMed/NCBI
8	Wada T, Nakashima T, Hiroshi N and Penninger JM: RANKL-RANK signaling in osteoclastogenesis and bone disease. Trends Mol Med. 12:17–25. 2006. View Article : Google Scholar : PubMed/NCBI
9	Asagiri M and Takayanagi H: The molecular understanding of osteoclast differentiation. Bone. 40:251–264. 2007. View Article : Google Scholar : PubMed/NCBI
10	Amano H, Yamada S and Felix R: Colony-stimulating factor-1 stimulates the fusion process in osteoclasts. J Bone Miner Res. 13:846–853. 1998. View Article : Google Scholar : PubMed/NCBI
11	Rachner TD, Khosla S and Hofbauer LC: Osteoporosis: Now and the future. Lancet. 377:1276–1287. 2011. View Article : Google Scholar : PubMed/NCBI
12	Boonen S, Reginster JY, Kaufman JM, Lippuner K, Zanchetta J, Langdahl B, Rizzoli R, Lipschitz S, Dimai HP, Witvrouw R, et al: Fracture risk and zoledronic acid therapy in men with osteoporosis. N Engl J Med. 367:1714–1723. 2012. View Article : Google Scholar : PubMed/NCBI
13	Jeong HS, Venkatesan J and Kim SK: Hydroxyapatite-fucoidan nanocomposites for bone tissue engineering. Int J Biol Macromol. 57:138–141. 2013. View Article : Google Scholar : PubMed/NCBI
14	Thinh PD, Menshova RV, Ermakova SP, Anastyuk SD, Ly BM and Zvyagintseva TN: Structural characteristics and anticancer activity of fucoidan from the brown alga sargassum mcclurei. Mar Drugs. 11:1456–1476. 2013. View Article : Google Scholar : PubMed/NCBI
15	Changotade S, Korb G, Bassil J, Barroukh B, Willig C, Colliec-Jouault S, Durand P, Godeau G and Senni K: Potential effects of a low-molecular-weight fucoidan extracted from brown algae on bone biomaterial osteoconductive properties. J Biomed Mater Res A. 87:666–675. 2008. View Article : Google Scholar : PubMed/NCBI
16	Park HS, Hwang HJ, Kim GY, Cha HJ, Kim WJ, Kim ND, Yoo YH and Choi YH: Induction of apoptosis by fucoidan in human leukemia U937 cells through activation of p38 MAPK and modulation of Bcl-2 family. Mar Drugs. 11:2347–2364. 2013. View Article : Google Scholar : PubMed/NCBI
17	Park SB, Chun KR, Kim JK, Suk K, Jung YM and Lee WH: The differential effect of high and low molecular weight fucoidans on the severity of collagen-induced arthritis in mice. Phytother Res. 24:1384–1391. 2010. View Article : Google Scholar : PubMed/NCBI
18	Yan-li C, Pei-pei W, Jun-ming Z and Song-song Z: Jian-wei: Extraction of fucoidan using multienzyme enzymolysis and their structural analysis, antioxidation research. Journal of Zhejiang University (Science Edition). 38:536–540. 2011.(In Chinese).
19	Mar Arriero M, Ramis JM, Perelló J and Monjo M: Inositol Hexakisphosphate inhibits osteoclastogenesis on RAW 264.7 cells and human primary osteoclasts. PloS One. 7:e431872012. View Article : Google Scholar : PubMed/NCBI
20	Livak KJ and Schmittgen TD: Analysis of relative gene expression data using real-time quantitative PCR and the 2(−Delta Delta C(T)) method. Methods. 25:402–408. 2001. View Article : Google Scholar : PubMed/NCBI
21	Carbonare L Dalle, Valenti MT, Bertoldo F, Zanatta M, Zenari S, Realdi G, Lo Cascio V and Giannini S: Bone microarchitecture evaluated by histomorphometry. Micron. 36:609–616. 2005. View Article : Google Scholar : PubMed/NCBI
22	Ma Z and Fu Q: Comparison of the therapeutic effects of yeast-incorporated gallium with those of inorganic gallium on ovariectomized osteopenic rats. Biol Trace Elem Res. 134:280–287. 2010. View Article : Google Scholar : PubMed/NCBI
23	Lum L, Wong BR, Josien R, Becherer JD, Erdjument-Bromage H, Schlöndorff J, Tempst P, Choi Y and Blobel CP: Evidence for a role of a tumor necrosis factor-alpha (TNF-alpha)-converting enzyme-like protease in shedding of TRANCE a TNF family member involved in osteoclastogenesis and dendritic cell survival. J Biol Chem. 274:13613–13618. 1999. View Article : Google Scholar : PubMed/NCBI
24	Cole AA and Walters LM: Tartrate-resistant acid phosphatase in bone and cartilage following decalcification and cold-embedding in plastic. J Histochem Cytochem. 35:203–206. 1987. View Article : Google Scholar : PubMed/NCBI
25	Chakrabarti S and Patel KD: Matrix metalloproteinase-2 (MMP-2) and MMP-9 in pulmonary pathology. Exp Lung Res. 31:599–621. 2005. View Article : Google Scholar : PubMed/NCBI
26	Delaissé JM, Engsig MT, Everts V, del Carmen Ovejero M, Ferreras M, Lund L, Vu TH, Werb Z, Winding B, Lochter A, et al: Proteinases in bone resorption: Obvious and less obvious roles. Clinica Chimica Acta. 291:223–234. 2000. View Article : Google Scholar
27	Ishida N, Hayashi K, Hoshijima M, Ogawa T, Koga S, Miyatake Y, Kumegawa M, Kimura T and Takeya T: Large scale gene expression analysis of osteoclastogenesis in vitro and elucidation of NFAT2 as a key regulator. J Biol Chem. 277:41147–41156. 2002. View Article : Google Scholar : PubMed/NCBI
28	Asagiri M, Sato K, Usami T, Ochi S, Nishina H, Yoshida H, Morita I, Wagner EF, Mak TW, Serfling E and Takayanagi H: Autoamplification of NFATc1 expression determines its essential role in bone homeostasis. J Exp Med. 202:1261–1269. 2005. View Article : Google Scholar : PubMed/NCBI
29	Matsuo K, Galson DL, Zhao C, Peng L, Laplace C, Wang KZ, Bachler MA, Amano H, Aburatani H, Ishikawa H and Wagner EF: Nuclear factor of activated T-cells (NFAT) rescues osteoclastogenesis in precursors lacking c-Fos. J Biol Chem. 279:26475–26480. 2004. View Article : Google Scholar : PubMed/NCBI
30	Zhao Q, Wang X, Liu Y, He A and Jia R: NFATc1: Functions in osteoclasts. Int J Biochem Cell Biol. 42:576–579. 2010. View Article : Google Scholar : PubMed/NCBI
31	Kong YY, Yoshida H, Sarosi I, Tan HL, Timms E, Capparelli C, Morony S, Oliveira-dos-Santos AJ, Van G, Itie A, et al: OPGL is a key regulator of osteoclastogenesis, lymphocyte development and lymph-node organogenesis. Nature. 397:315–323. 1999. View Article : Google Scholar : PubMed/NCBI
32	Nemeth K, Schoppet M, Al-Fakhri N, Helas S, Jessberger R, Hofbauer LC and Goettsch C: The role of osteoclast-associated receptor in osteoimmunology. J Immunol. 186:13–18. 2011. View Article : Google Scholar : PubMed/NCBI
33	Barrow AD, Raynal N, Andersen TL, Slatter DA, Bihan D, Pugh N, Cella M, Kim T, Rho J, Negishi-Koga T, et al: OSCAR is a collagen receptor that costimulates osteoclastogenesis in DAP12-deficient humans and mice. J Clin Invest. 121:3505–3516. 2011. View Article : Google Scholar : PubMed/NCBI
34	Yu M, Qi X, Moreno JL, Farber DL and Keegan AD: NF-κB signaling participates in both RANKL-and IL-4-induced macrophage fusion: Receptor cross-talk leads to alterations in NF-κB pathways. J Immunol. 187:1797–1806. 2011. View Article : Google Scholar : PubMed/NCBI
35	Liou SF, Hsu JH, Lin IL, Ho ML, Hsu PC, Chen LW, Chen IJ and Yeh JL: KMUP-1 suppresses RANKL-induced osteoclastogenesis and prevents ovariectomy-induced bone loss: Roles of MAPKs, Akt, NF-κB and calcium/calcineurin/NFATc1 pathways. PloS One. 8:e694682013. View Article : Google Scholar : PubMed/NCBI
36	McNamara LM: Perspective on post-menopausal osteoporosis: Establishing an interdisciplinary understanding of the sequence of events from the molecular level to whole bone fractures. J R Soc Interface. 7:353–372. 2010. View Article : Google Scholar : PubMed/NCBI
37	Brouwers JEM, Lambers FM, Gasser JA, van Rietbergen B and Huiskes R: Bone degeneration and recovery after early and late bisphosphonate treatment of ovariectomized wistar rats assessed by in vivo micro-computed tomography. Calcif Tissue Int. 82:202–211. 2008. View Article : Google Scholar : PubMed/NCBI
38	Boyd SK, Davison P, Müller R and Gasser JA: Monitoring individual morphological changes over time in ovariectomized rats by in vivo micro-computed tomography. Bone. 39:854–862. 2006. View Article : Google Scholar : PubMed/NCBI
39	Yoon KH, Cho DC, Yu SH, Kim KT, Jeon Y and Sung JK: The change of bone metabolism in ovariectomized rats: Analyses of microCT scan and biochemical markers of bone turnover. J Korean Neurosurg Soc. 51:323–327. 2012. View Article : Google Scholar : PubMed/NCBI
40	Wronski TJ, Schenk PA, Cintrón M and Walsh CC: Effect of body weight on osteopenia in ovariectomized rats. Calcif Tissue Int. 40:155–159. 1987. View Article : Google Scholar : PubMed/NCBI